A systematic review and network meta-analysis published in World Psychiatry reported that antipsychotic drugs had differing impacts on metabolic outcomes among patients with schizophrenia.
A systematic review and network meta-analysis published in World Psychiatry reported that antipsychotic drugs had differing impacts on metabolic outcomes among patients with schizophrenia.